ESR1 and breast carcinoma: In the subgroup analyses, isolated breast cancer patients with non‐DP experienced superior PFS than that with DP in the surgical group in ER/PR‐positive and ER/PR‐negative subgroups (HR: 0.39 and 0.57, both P < .05).